STOCK TITAN

Insider at PTCT (NASDAQ: PTCT) files Form 144 stock sale notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PTCT has a Form 144 notice covering the intended sale of 59 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $4,510.50 and an approximate sale date of January 8, 2026.

The 59 shares were acquired on January 7, 2026 via restricted stock vesting from the issuer as compensation. The filing also lists recent sales in the past three months by individuals named Neil G. Almstead and Zheng Y. Almstead, including 35,572 shares sold on November 24, 2025 for $2,852,153.65, 71,928 shares on November 25, 2025 for $6,001,524.59, and several smaller transactions on January 6–7, 2026 with proceeds ranging from $4,029.16 to $98,415.98.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many PTCT shares are covered by this Form 144 notice?

The Form 144 notice covers the proposed sale of 59 shares of PTCT common stock.

When and how were the 59 PTCT shares to be sold acquired?

The 59 common shares were acquired on January 7, 2026 through restricted stock vesting from the issuer as compensation.

What is the aggregate market value of the PTCT shares in this Form 144?

The aggregate market value of the 59 PTCT common shares covered by this notice is listed as $4,510.50.

Which broker and exchange are involved in the planned PTCT share sale?

The filing lists Fidelity Brokerage Services LLC as the broker and NASDAQ as the securities exchange for the planned sale.

What recent PTCT share sales are disclosed for the past three months?

The notice reports sales by Neil G. Almstead and Zheng Y. Almstead, including 35,572 shares sold on November 24, 2025 for $2,852,153.65 and 71,928 shares sold on November 25, 2025 for $6,001,524.59, plus several smaller sales on January 6–7, 2026.

What representation does the selling person make in this PTCT Form 144?

The selling person represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

5.49B
80.53M
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN